Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Post by yorgosGKon Apr 04, 2018 10:21am

129 Views

Post# 27827825

Simple Technicals

The "M" arcs of KALY. We thought news would break these arcs but 3 months of resistance and a horrible market has brought back a giant one; faking everyone out. The markets right now are horrifying - especially for marijuana plays (which is technically what we are). We don't know when the markets will fix, what we do know is KALY will be back : ) She comes back FAST....Markets should soon stop being bearish. Its been day 3 now. My prediction is that the buttom of the arc is around the corner. Here is why:

Support levels waiting to buttom feed the arc (as of 10:14AM):
User image